临床试验 妙佑医疗国际会定期在包括明尼苏达州、佛罗里达州和亚利桑那州在内的多个州进行各种一般性医疗保健主题的临床研究。 以下为当前的临床试验。14 研究 普通内科 （仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 Undiagnosed Tumor/Undifferentiated Mass Registry Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to create a research registry to prospectively collect research biospecimens and corresponding clinical data from subjects with an undiagnosed tumor or undifferentiated mass. GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will aid women at risk of breast cancer in making a decision to take (or not take) medications to prevent breast cancer. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS Rochester, Minn., Scottsdale/Phoenix, Ariz. The primary objective of the trial is to evaluate the long-term safety of glepaglutide treatment in patients with short bowel syndrome (SBS). Glepaglutide is the International Nonproprietary Name and USAN for ZP1848. Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women Rochester, Minn. This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical dysfunction in elderly women with gait disturbance. Positive results of this study would lead to the development of a larger clinical trial examining the effects of this intervention on age-related dysfunction. Pagination 临床研究 PrevPrevious Page Go to page 11 Go to page 22 以下为当前的临床试验。14 研究 普通内科 （仅限开放性研究）. 按位置、状态和其他条件筛选该研究列表。 Undiagnosed Tumor/Undifferentiated Mass Registry Rochester, Minn., Scottsdale/Phoenix, Ariz., Jacksonville, Fla. The purpose of this study is to create a research registry to prospectively collect research biospecimens and corresponding clinical data from subjects with an undiagnosed tumor or undifferentiated mass. GENetic Risk Estimation of Breast Cancer Prior to Decisions on Preventive Therapy Uptake, Risk Reducing Surgery or Intensive Imaging Surveillance Rochester, Minn., Jacksonville, Fla., Scottsdale/Phoenix, Ariz. The primary aim of this study is to determine if the addition of an individual polygenic risk score (PRS) in addition to the Breast Cancer Risk Assessment Tool (BCRAT) or Tyrer-Cuzick (IBIS) score will aid women at risk of breast cancer in making a decision to take (or not take) medications to prevent breast cancer. Evaluation of Long Term Safety and Efficacy of Glepaglutide in Treatment of SBS Rochester, Minn., Scottsdale/Phoenix, Ariz. The primary objective of the trial is to evaluate the long-term safety of glepaglutide treatment in patients with short bowel syndrome (SBS). Glepaglutide is the International Nonproprietary Name and USAN for ZP1848. Alleviation by Fisetin of Frailty, Inflammation, and Related Measures in Older Women Rochester, Minn. This is a pilot study to evaluate whether targeting inflammation will help reduce markers of insulin resistance inflammation, bone resorption and physical dysfunction in elderly women with gait disturbance. Positive results of this study would lead to the development of a larger clinical trial examining the effects of this intervention on age-related dysfunction. Pagination 临床研究 PrevPrevious Page Go to page 11 Go to page 22 申请预约 专业团队研究 April 25, 2024 Share on: FacebookTwitterWeChatWeChatCloseWeibo 普通内科部分概述医生专业团队临床试验研究患者故事费用与保险Mayo Clinic 新闻转诊 研究完全以患者为中心。 请参见副本 供视频使用 研究完全以患者为中心。 [音乐播放] 妙佑医疗国际神经学教授 Joseph Sirven 医学博士：妙佑医疗的使命以患者为中心。患者第一。我们的使命和研究是为了更好地帮助患者，提供以患者为中心的护理。在很多方面，这是一个循环。这个过程可能很简单，就是先在实验室里出现一个想法，然后带到病床旁加以实施，如果一切顺利，对患者有所助益， 就形成标准。我认为这就是妙佑医疗国际研究方法的一个独特之处，而这种以患者为中心的方式，也是妙佑医疗在众多医疗机构中脱颖而出的原因之一。 部分预约门诊概述医生专业团队临床试验研究患者故事费用与保险Mayo Clinic 新闻转诊 ORG-20461600 医学科室与中心 普通内科